NOT FDA-APPROVED FOR ANY USE
What is Semax?
Semax is a synthetic peptide fragment derived from adrenocorticotropic hormone (ACTH). It was developed and studied extensively in Russia, where it has been researched for cognitive-enhancing and neuroprotective properties, though it has not undergone FDA review.
Areas of Research Interest
- Cognitive function and memory research
- Neuroprotective pathway studies
- Brain-derived neurotrophic factor (BDNF) research
- Focus and attention studies
Regulatory Status
Semax is not FDA-approved for any use in the United States. While it has been studied and used in Russia under different regulatory frameworks, it has not completed FDA clinical trials and is classified as a research chemical in the U.S. context.
Educational information only. This content is not intended to diagnose, treat, cure, or prevent any disease, and does not provide guidance on personal use, dosing, or administration. Consult qualified professionals and current regulatory sources for guidance specific to your situation.